Iryna Tsvirinko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Iryna Tsvirinko has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Diana Zabolotna
State Institution “O.S. Kolomiychenko Institute of Otolaryngology of National Academy of Medical Science of Ukraine
6 shared publications - Eldar Ismahilov
State Institution “O.S. Kolomiychenko Institute of Otolaryngology of National Academy of Medical Science of Ukraine
2 shared publications - Vladyslav Nesterchuk
SI "Institute of Otolaryngology named after prof. O.S. Kolomiychenko National Academy of Sciences of Ukraine", Zoolohichna str., 3, Kyiv, 03057
2 shared publications - Yaroslav Kizim
State Institution “O.S. Kolomiychenko Institute of Otolaryngology of National Academy of Medical Science of Ukraine
2 shared publications - Dmitry I. Zabolotnyi
State Institution “O.S. Kolomiychenko Institute of Otolaryngology of National Academy of Medical Science of Ukraine”; Kyiv, Ukraine
1 shared publication - Dmitry Zabolotnyi
State Institution “Institute of otolaryngology named after Prof. O.S. Kolomiychenko of the National Academy of Medical Sciences of Ukraine”; Kyiv, Ukraine
1 shared publication
Latest Publications
- Open Access
- 31 December 2025
- Published by Ukrainian Military Medical Academy in Ukrainian Journal of Military Medicine
- Vol. 6 (4) , 116-120
Особливості клінічного перебігу грибкового алергічного риносинуситу у військовослужбовців
Вступ. Алергічний грибковий риносинусит (АГРС) – підтип хронічного риносинуситу з поліпами, який характеризується наявністю носових поліпів, продукцією густого еозинофільного муцину та експансивними змінами уражених приносових пазух. Патогенез пов’язаний із імуноглобулін Е-опосередкованою гіперчутливістю І типу до грибкових антигенів. Основним методом лікування АГРС є хірургічне втручання. Мета. Визначити особливості перебігу алергічного грибкового риносинуситу у військовослужбовців порівняно з цивільними пацієнтами. Матеріали і методи. У період з червня 2022 по червень 2025 року на базі відділення запальних захворювань ЛОР-органів ДУ «Інститут отоларингології ім. проф. О.С. Коломійченка НАМН України» було обстежено та проліковано 43 пацієнти з ознаками АГРС. Середній вік обстежених становив 48,9 року. Чоловіки складали 67,4% (n=29), жінки – 32,6% (n=14). До І групи увійшли 31 цивільний пацієнт, до ІІ групи – 12 військовослужбовців. Результати. У пацієнтів ІІ групи переважало двобічне ураження приносових пазух (83,3%), тоді як серед пацієнтів І групи частіше відзначався однобічний процес (58,1%). Головний біль постійного характеру спостерігався у 64,5% хворих І групи та у 100% пацієнтів ІІ групи. У 80,6% пацієнтів І групи скарги тривали понад 3 роки, тоді як усі пацієнти ІІ групи (100%) зазначали тривалість симптомів менше 3 років. Погіршення назальних симптомів після перенесеного COVID-19 вказали 32,3% пацієнтів І групи, тоді як жоден пацієнт ІІ групи не відзначав подібного впливу інфекції. Висновки. Перебіг захворювання у військовослужбовців (ІІ група) характеризувався більш швидким розвитком і агресивним клінічним перебігом порівняно з цивільними пацієнтами (І група). У військовослужбовців алергічний грибковий риносинусит частіше спостерігався з обох сторін (83,3%), порівняно з цивільними (41,9%). Головний біль спостерігався у всіх військовослужбовців з АГРС, на відміну від цивільних пацієнтів, де головний біль був присутній у 64,5% хворих. Розвиток захворювання згідно даних анамнезу у пацієнтів ІІ групи перебігав швидше і агресивніше. На відміну від цивільних пацієнтів, у військовослужбовців впливу COVID-19 на виникнення чи перебіг захворювання не спостерігалося. Згідно даних нашого дослідження рецидиви спостерігалися в усіх групах і достовірної різниці між ними не було виявлено.
- 31 December 2025
- Published by Ukrainian Military Medical Academy in Ukrainian Journal of Military Medicine
- Vol. 6 (4) , 116-120
Open AccessОсобливості клінічного перебігу грибкового алергічного риносинуситу у військовослужбовців
Вступ. Алергічний грибковий риносинусит (АГРС) – підтип хронічного риносинуситу з поліпами, який характеризується наявністю носових поліпів, продукцією густого еозинофільного муцину та експансивними змінами уражених приносових пазух. Патогенез пов’язаний із імуноглобулін Е-опосередкованою гіперчутливістю І типу до грибкових антигенів. Основним методом лікування АГРС є хірургічне втручання. Мета. Визначити особливості перебігу алергічного грибкового риносинуситу у військовослужбовців порівняно з цивільними пацієнтами. Матеріали і методи. У період з червня 2022 по червень 2025 року на базі відділення запальних захворювань ЛОР-органів ДУ «Інститут отоларингології ім. проф. О.С. Коломійченка НАМН України» було обстежено та проліковано 43 пацієнти з ознаками АГРС. Середній вік обстежених становив 48,9 року. Чоловіки складали 67,4% (n=29), жінки – 32,6% (n=14). До І групи увійшли 31 цивільний пацієнт, до ІІ групи – 12 військовослужбовців. Результати. У пацієнтів ІІ групи переважало двобічне ураження приносових пазух (83,3%), тоді як серед пацієнтів І групи частіше відзначався однобічний процес (58,1%). Головний біль постійного характеру спостерігався у 64,5% хворих І групи та у 100% пацієнтів ІІ групи. У 80,6% пацієнтів І групи скарги тривали понад 3 роки, тоді як усі пацієнти ІІ групи (100%) зазначали тривалість симптомів менше 3 років. Погіршення назальних симптомів після перенесеного COVID-19 вказали 32,3% пацієнтів І групи, тоді як жоден пацієнт ІІ групи не відзначав подібного впливу інфекції. Висновки. Перебіг захворювання у військовослужбовців (ІІ група) характеризувався більш швидким розвитком і агресивним клінічним перебігом порівняно з цивільними пацієнтами (І група). У військовослужбовців алергічний грибковий риносинусит частіше спостерігався з обох сторін (83,3%), порівняно з цивільними (41,9%). Головний біль спостерігався у всіх військовослужбовців з АГРС, на відміну від цивільних пацієнтів, де головний біль був присутній у 64,5% хворих. Розвиток захворювання згідно даних анамнезу у пацієнтів ІІ групи перебігав швидше і агресивніше. На відміну від цивільних пацієнтів, у військовослужбовців впливу COVID-19 на виникнення чи перебіг захворювання не спостерігалося. Згідно даних нашого дослідження рецидиви спостерігалися в усіх групах і достовірної різниці між ними не було виявлено.
- Open Access
- 26 December 2025
- Published by Professional Event, LLC in Family medicine. European practices
- No. 4,p. 120-126
Modern Aspects of Pathophysiology, Diagnosis and Treatment of Allergic Fungal Rhinosinusitis (Literature review)
Allergic fungal rhinosinusitis (AFRS) is classified as a primary, localized, with Th2-inflammatory response rhinosinusitis. It is characterized by the presence of nasal polyps, production of typical thick eosinophilic mucin, and expansive changes in the affected paranasal sinuses. The diagnosis is based on the diagnostic criteria which were established by John P. Bent, and Frederich A. Kuhn, which are met by 5 to 10% of all cases of chronic rhinosinusites. AFRS is more common in men and presents at a mean age range of 21–33 years. AFRS is a non-invasive form of fungal rhinosinusitis and usually affects individuals with atopy and type I hypersensitivity to fungi. Up to 24% of patients also have bronchial asthma. The mucin has a thick, sticky consistency, which is often described as “peanut butter-like”. Affected sinuses frequently undergo expansive changes that lead to erosion of bony structures. Patients with AFRS are unable to effectively clear fungal spores from the environment. This leads to the epithelial barrier dysfunction and the release of cytokines such as Interleukin (IL)-25, IL-33, and thymic stromal lymphopoietin. This triggers a type 2 immune response and initiates an inflammatory cascade that leads to eosinophilia, nasal polyposis, and the formation of eosinophilic mucin. Surgical intervention is the primary and most essential step in the treatment of AFRS. The goals of surgery include removal of eosinophilic mucin, which contains fungi that provoke and sustain sinus inflammation, excision of nasal polyps, and wide opening of the sinus cavities to facilitate postoperative sinus irrigation and local therapy. Biological medications represent a promising direction for the treatment of chronic rhinosinusitis, especially in patients with comorbid patology such as asthma. The high risk of recurrence highlights the need for further research into new treatment methods and the development of standardized care protocols for future patient management.
- 26 December 2025
- Published by Professional Event, LLC in Family medicine. European practices
- No. 4,p. 120-126
Open AccessModern Aspects of Pathophysiology, Diagnosis and Treatment of Allergic Fungal Rhinosinusitis (Literature review)
Allergic fungal rhinosinusitis (AFRS) is classified as a primary, localized, with Th2-inflammatory response rhinosinusitis. It is characterized by the presence of nasal polyps, production of typical thick eosinophilic mucin, and expansive changes in the affected paranasal sinuses. The diagnosis is based on the diagnostic criteria which were established by John P. Bent, and Frederich A. Kuhn, which are met by 5 to 10% of all cases of chronic rhinosinusites. AFRS is more common in men and presents at a mean age range of 21–33 years. AFRS is a non-invasive form of fungal rhinosinusitis and usually affects individuals with atopy and type I hypersensitivity to fungi. Up to 24% of patients also have bronchial asthma. The mucin has a thick, sticky consistency, which is often described as “peanut butter-like”. Affected sinuses frequently undergo expansive changes that lead to erosion of bony structures. Patients with AFRS are unable to effectively clear fungal spores from the environment. This leads to the epithelial barrier dysfunction and the release of cytokines such as Interleukin (IL)-25, IL-33, and thymic stromal lymphopoietin. This triggers a type 2 immune response and initiates an inflammatory cascade that leads to eosinophilia, nasal polyposis, and the formation of eosinophilic mucin. Surgical intervention is the primary and most essential step in the treatment of AFRS. The goals of surgery include removal of eosinophilic mucin, which contains fungi that provoke and sustain sinus inflammation, excision of nasal polyps, and wide opening of the sinus cavities to facilitate postoperative sinus irrigation and local therapy. Biological medications represent a promising direction for the treatment of chronic rhinosinusitis, especially in patients with comorbid patology such as asthma. The high risk of recurrence highlights the need for further research into new treatment methods and the development of standardized care protocols for future patient management.
- 1 January 2025
- Published by Vistka LTD in OTORHINOLARYNGOLOGY
- Vol. 8 (1-2) , 46-51
EXTRAOSSEOUS AMELOBLASTOMA OF THE MAXILLARY SINUS: A CLINICAL CASE
Relevance: Ameloblastoma is a rare benign epithelial tumour, considered the most aggressive among benign odontogenic tumours, with a recurrence risk of up to 50% within the first 5 years after treatment. Tumours of the upper jaw are more complex due to their proximity to vital anatomical structures, requiring special attention in diagnosis and treatment. Objective: To draw attention to maxillary ameloblastoma as a rare, aggressive, benign tumour through a clinical case example, highlighting treatment methods and recurrence prevention strategies. Materials and Methods: A patient with complaints of unilateral nasal congestion, difficulty in nasal breathing, and headaches for 6 months was examined at the Department of Inflammatory Diseases of the State Institution “O.S. Kolomiychenko Institute of Otolaryngology of National Academy of Medical Sciences of Ukraine”. Radiological imaging was performed, specifically computed tomography with intravenous contrast enhancement using Tomohexol. Results and Discussion: CT revealed a soft tissue mass with irregular, indistinct contours on the right side, extending from the upper-medial parts of the maxillary sinus into the nasal cavity. Remodelling of the posterior-lateral wall of the right maxillary sinus was observed. A decision was made to perform endoscopic endonasal tumor removal. During surgery, endoscopic partial septoplasty, right-sided endonasal partial antrostomy type II (TEMP-II), ethmoidotomy, and frontotomy were performed. Extraosseous/peripheral ameloblastoma is the rarest variant of ameloblastoma, predominantly affecting individuals aged 40 to 60, with a slight male predominance – fully consistent with our clinical case. Typically, this tumor does not involve bone destruction, although superficial bone erosion may occur, which distinguishes our patient’s case from descriptions in the literature. The treatment of choice is complete tumour resection with 1-2 cm margins within healthy tissue. There is no evidence supporting chemotherapy or radiation therapy. Conclusions. Ameloblastoma remains poorly understood and, despite its rarity, can affect the maxillary sinuses. Radical resection and regular follow-up are key to successful treatment, as this tumour, despite its benign nature, carries a high risk of recurrence. Keywords: Ameloblastoma, maxilla, neoplasm, odontogenic tumour.
- 1 January 2025
- Published by Vistka LTD in OTORHINOLARYNGOLOGY
- Vol. 8 (1-2) , 46-51
EXTRAOSSEOUS AMELOBLASTOMA OF THE MAXILLARY SINUS: A CLINICAL CASE
Relevance: Ameloblastoma is a rare benign epithelial tumour, considered the most aggressive among benign odontogenic tumours, with a recurrence risk of up to 50% within the first 5 years after treatment. Tumours of the upper jaw are more complex due to their proximity to vital anatomical structures, requiring special attention in diagnosis and treatment. Objective: To draw attention to maxillary ameloblastoma as a rare, aggressive, benign tumour through a clinical case example, highlighting treatment methods and recurrence prevention strategies. Materials and Methods: A patient with complaints of unilateral nasal congestion, difficulty in nasal breathing, and headaches for 6 months was examined at the Department of Inflammatory Diseases of the State Institution “O.S. Kolomiychenko Institute of Otolaryngology of National Academy of Medical Sciences of Ukraine”. Radiological imaging was performed, specifically computed tomography with intravenous contrast enhancement using Tomohexol. Results and Discussion: CT revealed a soft tissue mass with irregular, indistinct contours on the right side, extending from the upper-medial parts of the maxillary sinus into the nasal cavity. Remodelling of the posterior-lateral wall of the right maxillary sinus was observed. A decision was made to perform endoscopic endonasal tumor removal. During surgery, endoscopic partial septoplasty, right-sided endonasal partial antrostomy type II (TEMP-II), ethmoidotomy, and frontotomy were performed. Extraosseous/peripheral ameloblastoma is the rarest variant of ameloblastoma, predominantly affecting individuals aged 40 to 60, with a slight male predominance – fully consistent with our clinical case. Typically, this tumor does not involve bone destruction, although superficial bone erosion may occur, which distinguishes our patient’s case from descriptions in the literature. The treatment of choice is complete tumour resection with 1-2 cm margins within healthy tissue. There is no evidence supporting chemotherapy or radiation therapy. Conclusions. Ameloblastoma remains poorly understood and, despite its rarity, can affect the maxillary sinuses. Radical resection and regular follow-up are key to successful treatment, as this tumour, despite its benign nature, carries a high risk of recurrence. Keywords: Ameloblastoma, maxilla, neoplasm, odontogenic tumour.
- Open Access
- 29 December 2022
- Published by Dnipro State Medical University in Medicni perspektivi
- Vol. 27 (4) , 74-86
Radiological research methods in the diagnosis and treatment of patients with the parapharyngeal space tumors
The parapharyngeal space is a complex structure, being narrow and difficult for surgical approach. Surgical treatment is the main treatment for parapharyngeal space (PPS) tumors, it is performed on the basis of information obtained from imaging methods (computed tomography (CT) and magnetic resonance imaging (MRI)). Objective – to investigate the effectiveness of advanced visualization of radiological research methods in the diagnosis of the parapharyngeal space tumors in order to select the necessary tactics of surgical treatment. This retrospective study included 43 patients who underwent surgery for primary parapharyngeal space tumors from 2010 to 2021. 32 patients were treated in previous 10 years, 11 – patients who underwent examination and surgical treatment over the past 2 years with advanced methods of MRI and CT to select a safe surgical approach. Patients of the 2nd group underwent advanced MRI and CT studies in order to choose the correct method of surgical approach and prevent postoperative complications and recurrence. The histological conclusion in 90.1% of the operated patients confirmed the preliminary data of MRI perfusion regarding the probable histological structure of the neoplasm. Due to a comprehensive preoperative study, in 81.8% of patients in this group transoral approach was used. Our experience confirms the necessity for a thorough preoperative diagnostic procedure that should take advantage of imaging modalities (CT, MRI), especially new techniques (MRI-perfusion and diffusion weighted imaging).
- 29 December 2022
- Published by Dnipro State Medical University in Medicni perspektivi
- Vol. 27 (4) , 74-86
Open AccessRadiological research methods in the diagnosis and treatment of patients with the parapharyngeal space tumors
The parapharyngeal space is a complex structure, being narrow and difficult for surgical approach. Surgical treatment is the main treatment for parapharyngeal space (PPS) tumors, it is performed on the basis of information obtained from imaging methods (computed tomography (CT) and magnetic resonance imaging (MRI)). Objective – to investigate the effectiveness of advanced visualization of radiological research methods in the diagnosis of the parapharyngeal space tumors in order to select the necessary tactics of surgical treatment. This retrospective study included 43 patients who underwent surgery for primary parapharyngeal space tumors from 2010 to 2021. 32 patients were treated in previous 10 years, 11 – patients who underwent examination and surgical treatment over the past 2 years with advanced methods of MRI and CT to select a safe surgical approach. Patients of the 2nd group underwent advanced MRI and CT studies in order to choose the correct method of surgical approach and prevent postoperative complications and recurrence. The histological conclusion in 90.1% of the operated patients confirmed the preliminary data of MRI perfusion regarding the probable histological structure of the neoplasm. Due to a comprehensive preoperative study, in 81.8% of patients in this group transoral approach was used. Our experience confirms the necessity for a thorough preoperative diagnostic procedure that should take advantage of imaging modalities (CT, MRI), especially new techniques (MRI-perfusion and diffusion weighted imaging).
- 31 October 2022
- Published by Vistka LTD in OTORHINOLARYNGOLOGY
- No. No5(5) 202,p. 63-70
History and modern aspects of treatment of juvenile nasopharyngeal angiofibroma
Juvenile nasopharyngeal angiofibroma (JNA) is a rare benign tumor that is clinically manifested by epistaxis, usually occurs in males aged 9–27 years and accounts for approximately 0.5% of all head and neck tumors. The article presents historical data on the diagnosis and treatment of JNA. Modern views on the etiology of JNA are also represented. The development of such areas of medicine as anesthesiology (intubation, adequate analgesia and anesthesia, hemosubstitution, resuscitation), neuroradiology, endovascular surgery contributed to a further push in solving the problem of JNA. Attempts to visualize and treat this tumor have accompanied the evolution of the surgical treatment of juvenile nasopharyngeal angiofibroma. Today, the problem of JNA surgery is one of the most controversial and relevant in modern otolaryngology and neurosurgery. The key to this problem is the optimal choice of access to JNA. The article presents the results of treatment of 32 patients with JNA in the State Institution “Kolomiychenko Institute of Otolaryngology of NAMS of Ukraine. All patients underwent surgery by endoscopic endonasal approach. Selective angiography with embolization was performed only in patients with stages II and III according to Fisch classification. Patients with stage I did not receive embolization. The study protocol included CT and MRI examinations with intravenous contrast to determine the diagnosis and determine the stage of the tumor according to Fisch. Tumor recurrence was observed in 2 patients, and these patients had stage II according to Fisch. Tumor recurrence in all cases was observed in the pterygopalatine fossa area.
- 31 October 2022
- Published by Vistka LTD in OTORHINOLARYNGOLOGY
- No. No5(5) 202,p. 63-70
History and modern aspects of treatment of juvenile nasopharyngeal angiofibroma
Juvenile nasopharyngeal angiofibroma (JNA) is a rare benign tumor that is clinically manifested by epistaxis, usually occurs in males aged 9–27 years and accounts for approximately 0.5% of all head and neck tumors. The article presents historical data on the diagnosis and treatment of JNA. Modern views on the etiology of JNA are also represented. The development of such areas of medicine as anesthesiology (intubation, adequate analgesia and anesthesia, hemosubstitution, resuscitation), neuroradiology, endovascular surgery contributed to a further push in solving the problem of JNA. Attempts to visualize and treat this tumor have accompanied the evolution of the surgical treatment of juvenile nasopharyngeal angiofibroma. Today, the problem of JNA surgery is one of the most controversial and relevant in modern otolaryngology and neurosurgery. The key to this problem is the optimal choice of access to JNA. The article presents the results of treatment of 32 patients with JNA in the State Institution “Kolomiychenko Institute of Otolaryngology of NAMS of Ukraine. All patients underwent surgery by endoscopic endonasal approach. Selective angiography with embolization was performed only in patients with stages II and III according to Fisch classification. Patients with stage I did not receive embolization. The study protocol included CT and MRI examinations with intravenous contrast to determine the diagnosis and determine the stage of the tumor according to Fisch. Tumor recurrence was observed in 2 patients, and these patients had stage II according to Fisch. Tumor recurrence in all cases was observed in the pterygopalatine fossa area.
- Open Access
- 30 September 2022
- Published by European Scientific Platform (Publications) in Grail of Science
- No. 20,p. 169-174
OPTIMIZATION OF THE TRANSORAL METHOD OF ACCESS IN PATIENTS WITH NEOPLASMS OF THE PARAPHARYNGEAL SPACE
Primary tumors of the parapharyngeal space are rare and account for up to 0.5% of all neoplasms of the head and neck. 70-80% of these neoplasms are benign, 20-30% are malignant ones. Surgical treatment is the main method of treatment of tumors. The influence of a modified transoral access method on the presence of complications in the postoperative period was investigated. A comparison of various methods of transoral access in patients was carried out, by studying the presence of local complications and quality of life. The advantages of the modified transoral method of access are shown. The obtained results are discussed.
- 30 September 2022
- Published by European Scientific Platform (Publications) in Grail of Science
- No. 20,p. 169-174
Open AccessOPTIMIZATION OF THE TRANSORAL METHOD OF ACCESS IN PATIENTS WITH NEOPLASMS OF THE PARAPHARYNGEAL SPACE
Primary tumors of the parapharyngeal space are rare and account for up to 0.5% of all neoplasms of the head and neck. 70-80% of these neoplasms are benign, 20-30% are malignant ones. Surgical treatment is the main method of treatment of tumors. The influence of a modified transoral access method on the presence of complications in the postoperative period was investigated. A comparison of various methods of transoral access in patients was carried out, by studying the presence of local complications and quality of life. The advantages of the modified transoral method of access are shown. The obtained results are discussed.